Jee Hyun Kim

机构：Ulsan College, Seoul Metropolitan Government, Asan Medical Center, Seoul National University Bundang Hospital, University of Ulsan, Korea University · ORCID：0000-0003-1336-3620

发表论文 510 篇 · 总被引 15373 次 · h-index 53

代表论文

• Early Safety Results from the Phase 3b SIERRA Study of Durvalumab and Tremelimumab as First-Line Treatment for Participants with Unresectable Hepatocellular Carcinoma and a Poor Prognosis (2025 · Liver Cancer · 被引 3)
• Bevacizumab plus Erlotinib in Advanced Solid Cancers with Krebs Cycle Gene Mutations: A Multicenter Phase II Study (BRISK; KCSG AL22-16) (2025 · Clinical Cancer Research · 被引 1)
• Reversibility of immune checkpoint inhibitor-induced hypothyroidism (2025 · Endocrine Related Cancer · 被引 1)
• Roflumilast Inhibits Fibrogenic Activation in Human Intestinal Myofibroblasts via Inhibition of Myocardin-Related Transcription Factor/Serum Response Factor Signaling (2026 · International Journal of Molecular Sciences)
• Shared evolutionary trajectories underlying carcinogenesis and metastasis in biliary tract cancer (2026 · npj Precision Oncology)
• Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after two or more HER2-directed therapies (2026 · ESMO Open)